1. Introduction {#sec1}
===============

There is an ongoing trend for faster and better performing methods for nucleic acids detection and quantification. Especially when fighting diseases, it is important to have faster and cheaper diagnosis in order to reduce the response time, the stress on patients and the cost of the overall monitoring of large patient cohorts. This is for example the case for cancer screening ([@bib51]) or for population testing in rapidly evolving epidemics, as it has recently happened for COVID-19 ([@bib34]). Very reliable and quick assays are required, in order to detect several markers aiming to return more robust results. MicroRNAs (miRNA) are involved in many cellular processes, such as metabolism, cell growth, and proliferation. MiRNAs are expressed in tissue-specific manners and they are released in bodily fluids such as saliva, urine, and blood, where they are referred to as circulating miRNA ([@bib12]; [@bib15]; [@bib27]; [@bib47]; [@bib48]). The concentration of specific sets of miRNA in cells and bodily fluids is altered in pathological conditions, making them a useful class of diagnostic biomarkers for a large number of diseases, if not potentially for all physiological and pathological states ([@bib4]; [@bib7]; [@bib9]; [@bib40]; [@bib42]).

In bodily fluids, miRNAs are not present as simple, soluble and readily detectable RNA, rather they are commonly shuttled around inside stable extracellular lipid-based vesicles. In diagnostics and research, the RNA needs to be extracted from the patient\'s specimen first, by disassembling such vesicles, before any further analysis. After established molecular biology methods or commercial kits are used to obtain the short RNAs from the specimen, miRNAs are commonly detected and quantified with a choice of lab-based techniques, including qPCR, next generation sequencing or microarrays. Some drawbacks in such lab-based techniques make the detection and quantification of miRNA difficult. The short length of the target sequences, the high sequence homology between miRNAs with different biological roles and their low concentration in biological specimens represent some analytical challenges. Alternative methods and techniques are required in order to make it easier and more reliable to detect and quantitate miRNAs and so advance their uptake as diagnostic biomarkers for disease ([@bib24]; [@bib45]).

DNA-based biosensors can in principle overcome the complexity and cost of lab-based techniques ([@bib1]; [@bib13]). Of interest for miRNA detection, signal amplification strategies have been devised in order to extend the dynamic range of use of this class of biosensors and facilitate their uptake in diagnostics. Isothermal amplification methods involving DNA have been shown to overcome more complex PCR-based techniques in obtaining quantitative information about the presence of specific nucleic acids ([@bib18]). The hybridization chain reaction (HCR) is an enzyme-free isothermal amplification strategy based on the triggered self-assembly of two DNA hairpins in solution in the presence of a specific target sequence ([@bib19]). This reaction was proven to be largely adaptable to DNA-based sensing, leading to the enhancement of the sensitivity thanks to the formation of higher molecular weight structures. Promising applications of HCR in biosensing have been reported with various signal detection techniques ([@bib3]; [@bib5]). HCR can be exploited in order to accumulate an amount of DNA on a sensing surface: this can then be easily detected, for example, through Surface Plasmon Resonance (SPR) or other label-free techniques (see [Table S2](#appsec1){ref-type="sec"}). We showed that surface-bound HCR polymerization can be measured with SPR towards the detection of pathogen DNA ([@bib44]). Localized Surface Plasmon Resonance (LSPR) ([@bib50]), a phenomenon involving the interaction between light and metallic nanostructures, allows the realization of simple and small biosensors ([@bib10], [@bib11]; [@bib41]). In LSPR, the energy coupling is observable as a drop in the transmitted light, which yields a peak in the UV--vis absorbance spectrum of the nanoparticles ([@bib31]). A high sensitivity can be achieved by using a simple light source and a spectrophotometer ([@bib14]). LSPR has been proficiently harnessed towards biosensing ([@bib16]). DNA-based LSPR sensors have been used to detect microbial DNA or RNA and other DNA biomarkers after PCR amplification ([@bib23]; [@bib35]; [@bib39]; [@bib43]). Implementations of LSPR for the analysis of miRNA have been previously reported ([@bib30]; [@bib32]). Ki and coworkers demonstrated that coupling LSPR and HCR provides a gain in sensitivity in the detection ([@bib32]).

We herein propose an innovative and simple biosensor based on HCR and LSPR for the specific detection of miRNAs, and we test it towards the detection of miR-17 sequence. The novelty of the biosensor lies in its simple use of highly-specific hairpin surface probes and the direct connection between target-dependent surface HCR and subsequent LSPR signal generation. The simplicity and effectiveness of this approach make it amenable for diagnostic applications outside the research lab. Mir-17 was chosen as a target to test the biosensor since it is dysregulated in the blood of patients affected by different kinds of cancer and thus it is a promising biomarker for diagnosis and follow-up ([@bib6]; [@bib8]; [@bib21]; [@bib22]; [@bib25]; [@bib33]; [@bib55]; [@bib56]). For example, circulating mir-17 is increased in patients with lung cancer ([@bib37]) and with metastatic breast cancer ([@bib22]) or decreased in patients with gastric cancer ([@bib55]).

2. Material and methods {#sec2}
=======================

The LSPR setup employed in this work has been described before ([@bib46]); a brief description can be found in the Supplementary Information (SI).

The LSPR chips were obtained by immobilizing 80 nm gold nanoparticles on aminopropyl triethoxysilane (APTES)-treated glass slides (see SI, for further experimental details) ([@bib46]) and they could be stored for up to several days in a dry and clean atmosphere. Immediately before functionalization, the stored chips with the immobilized gold nanoparticles were rinsed with ethanol and ultrapure water, and subsequently subjected to a 1 min UV/Ozone treatment (UV ozone cleaner UVC-1014 NanoBioAnalytics, Berlin, Germany). The thiolated oligonucleotide probe, previously reduced with 20 mM tris(2-carboxyethyl)phosphine) (TCEP) for 1 h in ultrapure water, was adjusted to 2 μM in 0.5 M citrate buffer, pH 6.0, and was deposited on the chip in a controlled-humidity chamber. The probe was then incubated for 18 h at room temperature. After the incubation, the chips were rinsed with citrate buffer and ultrapure water, prior to storage in the running buffer before use (0.75 M NaCl, 75 mM sodium phosphate, pH 6.8). The oligonucleotide-derivatized chips were used within one day of preparation.

Probe-functionalized chips were mounted on the LSPR microfluidic cell and the different target, wash and DNA hairpin solutions were alternatively pumped over the chip surface (as described in the results section) thanks to computer-controlled valve switches. LSPR spectra were recorded every 2 s, the centroid of the LSPR peak was calculated in real-time and displayed ([@bib17]). Further details are given in the extended Methods section in the SI.

3. Results and discussion {#sec3}
=========================

We obtained the enhancement of a previously developed LSPR nucleic acid biosensor ([@bib46]; [@bib57]) by integrating surface HCR on it. This biosensor was reproduced by immobilizing 80 nm spherical gold nanoparticles on glass slides. Gold nanoparticles are chosen for their stability and ease of derivatization. Spherical 80 nm gold nanoparticles area a good compromise as they are stable, commercially available or easy to make in the lab and have a good plasmonic response ([@bib53]). They are expected to be sensitive to the neighboring solution environment up to a distance of about 40 nm ([@bib28]). Nanoparticles of alternative shapes or larger sizes could yield more sensitive LSPR biosensors but they would be more difficult to source, and more variable in shape, stability and plasmonic properties. The LSPR chips were prepared by adsorbing gold nanoparticles in crowded sub-monolayers. The amount of gold dispersion to use depends on its available concentration and it was optimized under AFM control (see [Fig. S1B](#appsec1){ref-type="sec"}) so that the large majority of the inter-particle distances was larger than the particle diameter and the plasmonic peak was narrow and reproducible (see SI text for more detail and [Fig. S2](#appsec1){ref-type="sec"}).

For surface derivatization, the immobilized nanoparticles were exposed to thiolated oligonucleotide probes. Differently from the previously presented versions of this type of biosensor, the nucleic-acid probe for miRNA recognition here was a DNA hairpin oligonucleotide with a 6-nt loop and a 6-nt overhang (see [Fig. S10](#appsec1){ref-type="sec"}) instead of a linear DNA oligonucleotide. This was chosen in order to maximize the sequence specificity of the interaction with the target, thanks to the energy penalty of the hairpin opening. Consequently, the recognition-dependent HCR reaction is triggered only in the case of complete sequence-specific hairpin unfolding, not simply upon binding of any sequence to the probe (see [Scheme 1](#sch1){ref-type="fig"} ). The hairpin probe was designed in the context of the guidelines for HCR ([@bib36]), and it was merely a thiolated version of one of the two HCR hairpin components. The probe-derivatized chips were passivated with mercaptohexanol (MCH) and salmon sperm DNA. The steps involved in the detection of this enhanced LSPR biosensor are sketched in [Scheme 1](#sch1){ref-type="fig"}.Scheme 1Scheme of the working principle of the proposed method based on LSPR sensing and Hybridization Chain Reaction (HCR). 1) The probe H1 is immobilized on the gold nanoparticles (GNP) 2) The specific miRNA target is added and it interacts with the specific probe. 3) The mixture of hairpins is added and 4) Hybridization chain reaction takes place on the gold nanoparticles. Each step is monitored using LSPR in real time. The nanoparticles and the DNA molecules are not drawn to scale.Scheme 1

After the glass slides with adsorbed probe-derivatized nanoparticles were prepared, they were mounted in the microfluidic cell and then buffer and DNA oligonucleotides mimicking miR-17 were circulated at 5 μl/min via a computer-controlled peristaltic pump. In order to work in more manageable conditions, our tests were performed with target DNA with the same sequence as the RNA sequences. We assume that our analytical system could be easily tunable to RNA detection at a later stage. An example of the real-time measurement of the centroid of the plasmonic peak is reported in [Fig. 1](#fig1){ref-type="fig"} B (together with example plasmonic spectra in [Fig. 1](#fig1){ref-type="fig"}A). The binding of miR-17 target led to a progressive shift of the centroid position over time. After flowing the analyte solution, a small amount of washing buffer was circulated in order to allow a differential measurement of the centroid shift in the same solution (refractive index) as the baseline (as indicated by the black bracket in [Fig. 1](#fig1){ref-type="fig"}B). After each measurement cycle, the biosensor surface was regenerated by flowing 20 mM HCl ([@bib57]) and verifying that the baseline centroid location was obtained again. A typical calibration curve of the system response is displayed in [Fig. 2](#fig2){ref-type="fig"} (blue trace) and was obtained from repeated measurements with varying concentrations of miR-17 target sequence, flowed at the same rate for the same time (10 min). For the sake of comparison of the signals, the shifts of the centroids of the plasmonic peaks of each biosensor were normalized to its shift in response to 1 μM analyte. This response to this maximum tested concentration of miR-17 was also considered as a practical index of the quality of the chip in use and a proof of an efficient probe immobilization. The biosensor response to the miR-17 target is linear with the log of the target concentration in the 1 nM-1 μM range (normalized Δcentroid = 0.31\*Log(conc./nM) + 0.05 with R^2^ = 0.993).Fig. 1A) Example spectra for the biosensors before (running buffer) and after exposure to target miR-17 oligonucleotide or full HCR. In the inset, the enlarged detail of the peaks showing the plasmonic shift (the running buffer peak is here centered at 540.6 nm, the target peak at 541.0 nm, the HCR at 541.5 nm). The spectra have been smoothed through polynomial fitting. B) Typical plot of the centroid position over time obtained during the measurement for miR-17 detection in running buffer. On the y-axis is the LSPR centroid wavelength (λ~LSPR~). The shifts (Δ in the figure) were calculated by taking the difference between the **λ**~**LSPR**~ peak position of the plasmonic sensor after and before the injection of miR-17. The concentration of miR-17 here was 1 μM (RB, running buffer; T, target miR-17 oligonucleotide; RE, regeneration solution).Fig. 1Fig. 2Calibration curve for the response of the miRNA biosensor, with and without HCR. Different concentrations of target miR-17 in running buffer were flowed in the chamber followed by injection of the mixture of hairpins at 0.5 μM each in running buffer for 30 min. The blue trace represents the calibration curve for the response to the target only, while the yellow trace represents the cumulative response after HCR amplification. The lower and upper dashed horizontal blue lines correspond to the LOD and the LOQ, respectively, for the biosensor response without HCR. The lower and upper dotted yellow horizontal lines represent the LOD and LOQ for the biosensor response with HCR amplification. The bars correspond to the standard deviations (N = 3). Only the first data point below LOD is plotted in the figure for the yellow HCR trace (C = 0.0001 nM), while the corresponding points are plotted for the blue target-only trace as to show the gain in LOD with HCR. See [Figs. S5 and S9](#appsec1){ref-type="sec"} for part of the raw data used for this calibration. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)Fig. 2

The effect of HCR on the calibration curve of the biosensor was tested by performing HCR after the exposure of the biosensor to known concentrations of the specific miR-17 target sequence ([Fig. 2](#fig2){ref-type="fig"}, yellow trace). After the non-bound target was removed by washing with running buffer, HCR hairpins were flowed simultaneously through the measurement cell at a constant concentration (0.5 μM for 0.5 h) for all the data points. This operation was performed via a peristaltic pump under computer control so that the overall operator effort was limited to setting up the apparatus. Including HCR made the measurement time 0.5 h longer to allow for the HCR molecular assembly to reach a plateau yield. Globally, the measurement procedure on a specimen took less than 1 h and 50 μl of target solution per measurement point. As shown in [Fig. 2](#fig2){ref-type="fig"}, signal gains of about 2-fold for 1 μM and 10 nM target concentration were recorded, while lower signals but due to slightly higher amplification ratios were recorded in the 1 pM--1 nM range. Thereby, we can conclude that the HCR decreased the LOD down to the pM target concentration range.

The hybridization chain reaction is often affected by some target-less *leakage* (the self-triggered assembly of the monomers) due to the metastable state of the hairpin monomers. The negative control (only buffer instead of target analyte exposed on the probe) shows a very low signal increase when the HCR hairpins are later circulated ([Fig. 2](#fig2){ref-type="fig"}). Since the chips were properly passivated (see [Fig. S7](#appsec1){ref-type="sec"}), this is probably due to some weak leakage that could not be suppressed while designing hairpins for the natural miR-17 sequence. The use of hairpins at the relatively low 0.5 μM concentration stems from the compromise between a reasonable rate of the HCR and low enough leakage.

We showed that it is also possible to reuse the biosensors as to allow for higher productivity/sensor (see [Fig. S3](#appsec1){ref-type="sec"}): this aspect could be useful towards research bioanalytics or environmental testing, but it is certainly not advisable in diagnostics in order to avoid cross-contaminations.

The Student t-test was performed to confirm that the measurements after HCR are statistically different from those before HCR (P ≤ 0.01) in the 1 pM-1 μM concentration range. The limit of detection (LOD) was estimated as the lowest (measured) target concentration with a signal higher than the signal of the blank added to 3 times its standard deviation. The limit of quantitation (LOQ) was estimated adding the signal of the blank to 10 times its standard deviation ([@bib2]). The LOD for the LSPR biosensor before the amplification step was estimated at 1 nM, with a LOQ of about 10 nM. HCR reduced the LOD and the LOQ to about 1 pM, suggesting an effective advantage of HCR as an amplification method ([Fig. 2](#fig2){ref-type="fig"}, LOD and LOQ are the lower and higher horizontal dashed lines, for both HCR-less and HCR-enhanced measurements). These LOD and LOQ values are in the proper range for miRNA detection in bodily fluids, where the concentrations are expected to range from femtomolar to nanomolar ([@bib58]). As the volume of each target analyte injection was 50 μL, the LSPR biosensor can detect about 50 amol of miRNA. The ability to operate with such small volumes of diluted miRNA solution should make our biosensor method compliant with the available volumes of patient specimens derived from liquid biopsies and the needed sample pre-processing and extraction procedures.

Previously reported LSPR based methods could in some cases reach slightly lower LODs than that herein reported, however they employed much more complicated setups and procedures. Ki et al. reported detecting 2.6 amol in a 200 μL sample, using complex nanostructured LSPR chips in combination with enzymatic substrate precipitation. The analysis time of the miRNA sensing platform, as commented by the authors themselves, was too long for direct assay as a point-of-care (POC) diagnostic tool in clinical application ([@bib32]). Our approach could achieve a similar LOD, and further technical improvements to our biosensor are still possible. The strategy reported by Joshi et al. for miRNA detection yielded a limit of detection of about 30 fM. It requires peculiar gold nanostructures and longer analysis times ([@bib30]). Moreover, the authors use a linear single-stranded probe and it is not clear if the authors verified that it can distinguish homologous miRNA sequences: a critical issue since diagnostic detection deals with a complex miRNA mix (*vide infra* our tests for non-target sequences). Na et al. presented a LSPR assay using HCR and DNAzyme activity as a double amplification, reaching a limit of detection of about 2 pM in buffer, not far from our findings. Their overall protocol required complex manipulation, transfer of the samples and time-consuming incubations ([@bib38]). We can thus state that our proposed biosensor can represent a viable result of simplicity, scalability and performance that should prove useful towards the POC sensing of miRNA of diagnostic interest. Further comparison with the available literature is presented in [Table S2](#appsec1){ref-type="sec"}.

The specific hairpin monomers H1 and H2 here employed were designed for miR-17 detection ([@bib36]). Their self-assembly was first demonstrated by us through experiments in solution (see section S4 in SI). An important issue in microRNA detection is the discrimination between similar sequences. The specificity of the system in solution was verified by testing the detection in the presence of miR-106b, with high sequence homology with miR-17, and in the presence of several other unrelated miRNA sequences (see [Figs. S14 and S15](#appsec1){ref-type="sec"}).

In order to test for the specificity of the LSPR biosensor detection, miR-21 and miR-106b non-target sequences were used ([Fig. 3](#fig3){ref-type="fig"} ). miR-21 is another commonly dysregulated miRNA in diseases such as cancer ([@bib52]), while, as mentioned above, miR-106b holds a very close sequence similarity to miR-17 (see [Table S3](#appsec1){ref-type="sec"}) so it was tested as a possible challenging interferent. The LSPR measurements of the alternative analytes were performed in the same conditions as the miR-17 targets (1 μM conc.) and the results are displayed in [Fig. 3](#fig3){ref-type="fig"} (blue bars). The system designed for detecting miR-17 displays a significantly higher signal (5-fold higher) as a response to miR-17 than to the highly homologous miR-106b and an even higher signal (10-fold) with respect to the same concentration of miR-21, which gave a barely detectable signal. Not only the signal due to the highly homologous miR-106b is much lower than that due to miR-17, but the kinetics of the change in the LSPR signal was also markedly different (see [Fig. S4](#appsec1){ref-type="sec"}). The Student t-test confirmed that the measurements after HCR are statistically different from those before HCR for miR-17 detection (P ≤ 0.01) while a statistically significant difference was not confirmed for the non-specific miR-106b and miR-21 (p-values are greater than 0.1).Fig. 3Test for the specificity of the biosensor: miR-17 probe and hairpins were tested with miR-17 and with highly-homologous miR-106b and with more significantly different miR-21. Normalized average shift in the centroid position are displayed corresponding to the miRNA sequence detection (blue bars) and the overall response performing HCR (orange bars). Error bars correspond to standard deviation (N = 3). The black line corresponds to the LOD (before HCR) as defined in [Fig. 1](#fig1){ref-type="fig"} and in the main text. Error bars correspond to standard deviation (N = 3). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)Fig. 3

As also described before, a second biosensor signal was then recorded after performing HCR for miR-17 to test for the extent and specificity of signal amplification. As showed in [Fig. 3](#fig3){ref-type="fig"}, HCR led to a significantly higher signal in the case of the specific target (2.5 fold higher). In the case of a non-specific binding, such as for miR-106b and miR-21, HCR still amplified the signal, albeit to some lower extent: the specific HCR signal is still about 5-fold higher than the non-specific one from the most homologous miR-106b.

The use of a hairpin surface-probe in the biosensor implies an energy penalty thwarting non-specific binding, due to the stable secondary structure of the hairpin stem that protects at least part of the recognition sequence. This type of probe is widely employed in sensing applications, including strategies involving so-called E-DNA or molecular beacons ([@bib20]; [@bib26]; [@bib29]; [@bib49]). In our case, a non-specific sequence should not be able to unpair the hairpin, while the totally specific complementary sequence induces the switch in the conformation, triggering the HCR self-assembly. The advantages of using a hairpin probe have been confirmed by thermodynamic analysis in NUPACK ([@bib54]): a linear single stranded probe for miR-17 would easily interact with miR-106b, while a much lower probability of interaction is found between hairpin H1 and miR-106b. This was confirmed by the experiments in solution that showed a very high specificity in the triggering with miR-17 *vs.* miR-106b (see [Fig. S14](#appsec1){ref-type="sec"}). The hairpin probe was designed to interact at the 3′ terminus of the miRNA (see [Fig. S12](#appsec1){ref-type="sec"}): this region has been observed to be more variable in miRNAs, and, in particular, miR-106b misses two bases at the 3' terminus, in addition to a guanine replaced with an adenine in the same region. These differences should impair the formation of the complex, enhancing the specificity. Moreover, a much slower assembly kinetics is expected, as this is strongly dependent on the base pairing at the hairpin toehold, which is reduced for miR-106b.

When performing HCR on the nanoparticle surface, a visible (though not very statistically significant, *vide supra*) HCR enhancement of the LSPR is also measured when testing for the non-specific miR-106b, albeit on a lower signal ([Fig. 3](#fig3){ref-type="fig"}). We can hypothesize that the immobilization of the probe on the gold surface could have an effect on the stability of the hairpin: the charge density, and the steric hindrance on the surface of the gold nanoparticles may slightly enhance the switching of H1 to a partially open conformation, more prone to non-specific triggering than the same sets of sequences when tested in solution (see [Fig. 3](#fig3){ref-type="fig"} *vs.* [Fig. S14](#appsec1){ref-type="sec"}). Local surface defects or chemical inhomogeneities near the probes could possibly lead to the higher signal variability found for this probe. Even if the specificity of the surface-bound hairpin probe was lower than in solution, our biosensor could clearly give a much higher signal with the specific miR-17 target than with miR-106b, the most homologous sequence found in the miRNA databases.

In our experimental set-up, the measurements and the fluidics are fully automated using pumps under the control of a custom-made software. A further obvious development of the sensing strategy and the measurement apparatus could entail the multiplexed HCR and measurement over a small number of miRNA-specific probes. In such envisaged development, the calibration of the system with non-specific miRNAs should allow for the subtraction of cross-over readings and improve the sequence specificity further from what reported here. This development is not expected to require novel technological components. Spherical gold nanoparticles are easily accessible, while light sources and spectrophotometers can be miniaturized allowing the portability and applicability in POC clinical analysis.

4. Conclusions {#sec4}
==============

We herein presented a novel combination of hybridization chain reaction and LSPR-based sensing towards the specific detection of short nucleic acids, such as circulating miRNA. The innovation lies in the combined use of hairpin probes for recognition specificity, and HCR for surface-bound isothermal enzyme-free amplification that directly yields an increased LSPR signal. We showed that our biosensing strategy is amenable to the detection of the diagnostically relevant miR-17 in clinically-relevant quantities and concentrations. Furthermore, the biosensor is robust in the presence of other interfering miRNA sequences, as a mix of miRNAs are expected to be always present in the samples processed from patients' bodily fluids. In our implementation, the full measurement procedure of one specimen can take less than 1 h.

Envisaged further developments of the apparatus fluidics and optical detection can multiplex the detection system as to allow the simultaneous specific and sensitive detection of a panel of diagnostically-relevant miRNA within the same response time in the context of POC diagnostics.
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